Pediatric lung transplant specialist Christian Benden, MD, described the future for children who need lung transplants: fewer ...

In separate small clinical trials, two treatments showed promise that they could help patients with one of the most dire ...

What is the significance of Path-IO and how could it contribute to clinical care? Immunotherapy has been a transformational ...

Thanks to major scientific breakthroughs, Dr. David Carbone says survival rates have doubled — and in some cases, patients ...

Macrophages, key regulators of tissue health and immune defense, are among the most abundant immune cells in solid tumors. Their role in cancer has been difficult to define because even closely ...

Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) today announced that the first patient has been successfully dosed in a phase Ⅱ clinical study evaluating ...

Daryl Pritchard, PhD, discusses the challenges to implementing biomarker testing that would advance precision medicine and ...

In lung cancer, surgical resection remains the primary curative treatment, particularly for early-stage Non-Small Cell Lung Cancer (NSCLC). To augment these ...

The mRNA-based Covid vaccines helped blunt the impact of the pandemic but also sparked political backlash that has threatened ...

The platform trial will add new arms testing Enhertu in solid tumors with HER2 amplification and gather data on Tafinlar-Mekinist's tissue-agnostic benefit for regular approval.

Ben Sasse was diagnosed with Stage 4 pancreatic cancer in December, he was given three to four months to live. Now a drug by Revolution Medicines is giving him precious more time with family and ...